Elsevier

Heart Rhythm

Volume 20, Issue 7, July 2023, Pages 992-997
Heart Rhythm

Clinical
Heart Faillure
Predicting all-cause mortality by means of a multisensor implantable defibrillator algorithm for heart failure monitoring

https://doi.org/10.1016/j.hrthm.2023.03.026Get rights and content

Background

The HeartLogic algorithm (Boston Scientific) has proved to be a sensitive and timely predictor of impending heart failure (HF) decompensation.

Objective

The purpose of this study was to determine whether remotely monitored data from this algorithm could be used to identify patients at high risk for mortality.

Methods

The algorithm combines implantable cardioverter-defibrillator (ICD)–measured accelerometer-based heart sounds, intrathoracic impedance, respiration rate, ratio of respiration rate to tidal volume, night heart rate, and patient activity into a single index. An alert is issued when the index crosses a programmable threshold. The feature was activated in 568 ICD patients from 26 centers.

Results

During median follow-up of 26 months [25th–75th percentile 16–37], 1200 alerts were recorded in 370 patients (65%). Overall, the time IN-alert state was 13% of the total observation period (151/1159 years) and 20% of the follow-up period of the 370 patients with alerts. During follow-up, 55 patients died (46 in the group with alerts). The rate of death was 0.25 per patient-year (95% confidence interval [CI] 0.17–0.34) IN-alert state and 0.02 per patient-year (95% CI 0.01–0.03) OUT of the alert state, with an incidence rate ratio of 13.72 (95% CI 7.62–25.60; P <.001). After multivariate correction for baseline confounders (age, ischemic cardiomyopathy, kidney disease, atrial fibrillation), the IN-alert state remained significantly associated with the occurrence of death (hazard ratio 9.18; 95% CI 5.27–15.99; P <.001).

Conclusion

The HeartLogic algorithm provides an index that can be used to identify patients at higher risk for all-cause mortality. The index state identifies periods of significantly increased risk of death.

Introduction

Implantable cardioverter-defibrillators (ICDs) and defibrillators for resynchronization therapy (cardiac resynchronization therapy defibrillator [CRT-D]) are widely adopted for the treatment of chronic heart failure (HF).1 Some modern ICDs are equipped with automated algorithms that provide detailed information on the patient’s HF condition on a daily basis. Many studies have reported combining ICD diagnostics in order to better stratify and manage patients at risk for HF events.2, 3, 4 In the MultiSENSE (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients) study,5 a novel algorithm for HF monitoring was implemented: the HeartLogicTM (Boston Scientific, St. Paul, MN) index, which combines physiological data from multiple ICD-based sensors. The index enabled dynamic assessment of HF, identifying periods when patients were at significantly increased risk for worsening HF.6 However, no study has explored whether the index predicts all-cause death. In the present study, we sought to determine whether remotely monitored data from this algorithm could be used to identify patients at high risk for mortality, and whether its predictive ability was independent of the patient’s demographic and clinical variables.

Section snippets

Patient selection

The study was a prospective, nonrandomized, multicenter evaluation of patients who had received an ICD or CRT-D having the HeartLogic diagnostic algorithm. Consecutive HF patients with reduced left ventricular ejection fraction (≤35% at the time of implantation) who had received a device in accordance with standard indications1 and were enrolled in the LATITUDE (Boston Scientific) remote monitoring platform were included at 26 study centers (full list of participating centers is given in the

Study population

From December 2017 to June 2021, HeartLogic was activated in 568 patients who had received an ICD (n = 158) or CRT-D (n = 410). Baseline clinical variables of all patients in the present analysis are listed in Table 1.

Follow-up

During median follow-up of 26 months [16–37], 55 patients (10%) died. According to local site adjudication, 33 deaths were from cardiovascular causes. One or more appropriate ICD shocks were documented in 74 patients (13%). The HeartLogic index crossed the threshold value 1200

Discussion

In the present study, we demonstrated the ability of the HeartLogic algorithm to identify subjects at high risk for death among HF patients who had received ICD and CRT-D. The occurrence of at least 1 HeartLogic alert and a time IN alert ≥20% were significantly associated with mortality due to any cause. Moreover, the rate of fatal events was substantially higher with the HeartLogic IN the alert state, and the association between the alert state and mortality was confirmed even after correction

References (24)

  • T.A. McDonagh et al.

    2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure

    Eur Heart J

    (2021)
  • M.R. Cowie et al.

    Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting

    Eur Heart J

    (2013)
  • Funding Sources: The authors have no funding sources to disclose. Disclosures: Ms Monica Campari and Dr Sergio Valsecchi are employees of Boston Scientific, Inc. All other authors have no conflicts of interest to disclose. ClinicalTrials.gov Identifier: NCT02275637.

    View full text